Ginkgo Bioworks Holdings Stock Analysis

Ginkgo Stock Analysis Notes

About 69.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.46. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ginkgo Bioworks Holdings recorded a loss per share of 12.89. The entity had not issued any dividends in recent years. The firm had 1:40 split on the 20th of August 2024. Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. Ginkgo Bioworks operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 641 people. To learn more about Ginkgo Bioworks Holdings call Jason Kelly at 877 422 5362 or check out https://www.ginkgobioworks.com.

Ginkgo Bioworks Holdings Investment Alerts

Ginkgo Bioworks Holdings Upcoming and Recent Events

Ginkgo Largest EPS Surprises

View All Earnings Estimates

Ginkgo Bioworks Environmental, Social, and Governance (ESG) Scores

Ginkgo Bioworks Thematic Classifications

Ginkgo Stock Institutional Investors

Note, although Ginkgo Bioworks' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ginkgo Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 370.74 M.

Ginkgo Profitablity

The company has Net Profit Margin of (2.99) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.59) %, which entails that for every $100 of revenue, it lost $0.59.

Management Efficiency

Ginkgo Bioworks Holdings has Return on Asset of (0.2092) % which means that on every $100 spent on assets, it lost $0.2092. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.6351) %, meaning that it generated no profit with money invested by stockholders. Ginkgo Bioworks' management efficiency ratios could be used to measure how well Ginkgo Bioworks manages its routine affairs as well as how well it operates its assets and liabilities. As of November 21, 2024, Return On Tangible Assets is expected to decline to -0.61. In addition to that, Return On Capital Employed is expected to decline to -0.6. At present, Ginkgo Bioworks' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 107.1 M, whereas Net Tangible Assets are forecasted to decline to about 1.1 B.

Technical Drivers

As of the 21st of November, Ginkgo Bioworks retains the Market Risk Adjusted Performance of (0.04), risk adjusted performance of (0.01), and Standard Deviation of 6.03. Ginkgo Bioworks technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Ginkgo Bioworks Holdings Price Movement Analysis

Ginkgo Bioworks Holdings Insider Trading Activities

Ginkgo Bioworks Predictive Daily Indicators

Ginkgo Bioworks Corporate Filings

Ginkgo Bioworks Forecast Models

Ginkgo Bioworks' time-series forecasting models are one of many Ginkgo Bioworks' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ginkgo Bioworks' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ginkgo Bioworks prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ginkgo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ginkgo Bioworks. By using and applying Ginkgo Stock analysis, traders can create a robust methodology for identifying Ginkgo entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ginkgo analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ginkgo analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Ginkgo Bioworks Holdings stock analysis indicators help investors evaluate how Ginkgo Bioworks stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Ginkgo Bioworks shares will generate the highest return on investment. By understating and applying Ginkgo Bioworks stock analysis, traders can identify Ginkgo Bioworks position entry and exit signals to maximize returns.

When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.